Hernando Trujillo
2 Papers
Hernando Trujillo is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 2, co-authored 2 publications.
Chat about Author
Papers
The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy
Gema Fernández-Juárez,Jorge Rojas-Rivera,Anne-Els van de Logt,Joana Justino,Angel Sevillano,Fernando Caravaca-Fontán,Ana Ávila,Cristina Rabasco,Virginia Cabello,Alfonso Varela,Montserrat Díez,Guillermo Martín-Reyes,Marian Goicoechea Diezhandino,Luis F. Quintana,Irene Agraz,Juan Ramón Gómez-Martino,Mercedes Cao,Antolina Rodríguez-Moreno,Begoña Rivas,Cristina Galeano,Jose Bonet,Ana María Romera,Amir Shabaka,Emmanuelle Plaisier,Emmanuelle Plaisier,Mario Espinosa,Jesús Egido,Alfonso Segarra,Gérard Lambeau,Pierre Ronco,Pierre Ronco,Jack F.M. Wetzels,Manuel Praga,Hernando Trujillo,Eduardo Gutiérrez,Gema Fernandez Juarez,Alberto Ortiz,Marian Goicoechea,Ursula Verdalles,Alfons Segarra,Lara Perea,Ildefonso Valera,Mónica Martín,Miguel Angel Pérez Valdivia,Miquel Blasco,Andrés López Muñiz,Tamara Malek,Montserrat Diaz,Iara daSilva,Jordi Bonet,Maruja Navarro,Ana Huerta,Ezequiel Rodríguez-Paternina,Ana Vigil,Roberto Alcázar,Vicente Paraiso,Vicente Barrio,Julia M. Hofstra +57 more
TL;DR: Treatment with corticosteroid-cyclophosphamide induced remission in a significantly greater number of patients with primary membranous nephropathy than tacrolimus-rituximab, and serious adverse events were similar in both groups.
171
Validation of a Histologic Scoring Index for C3 Glomerulopathy
Fernando Caravaca-Fontán,Hernando Trujillo,Marina Alonso,Montserrat Díaz-Encarnación,Virginia Cabello,Gema Ariceta,Luis F. Quintana,Helena Marco,Xoana Barros,Natalia Ramos,Nuria Rodríguez-Mendiola,Sonia Cruz,Gema Fernández-Juárez,Eva Rodríguez,Francisco de la Cerda,Ana Pérez de José,Inmaculada López,Loreto Fernández,Vanessa Pérez Gómez,Ana Ávila,Luis Bravo,Javier Lumbreras,Natalia Allende,Maria Dolores Sanchez de la Nieta,Teresa Olea,Marta Melgosa,Ana Huerta,Rosa Miquel,Carmen Mon,Gloria Fraga,Alberto Lorenzo,Juliana Draibe,F. González,Amir Shabaka,Maria Luisa Illescas,Consuelo Calvo,Victoria Oviedo,Iara Da Silva,Elena Goicoechea de Jorge,Elena Goicoechea de Jorge,Francisco Caravaca,Manuel Praga,Teresa Cavero,Angel Sevillano,Eduardo Gutiérrez,Enrique Morales,Lucia González,Rafael Camacho Galán,Alejandra Gabaldón Domínguez,Marta Garrido,Alexandra Navarro,José Antonio Cortés,Alejando Pascual Martin,M. Luisa Pérez-Ebri,Rocío Cabrera-Pérez,Ángel Panizo Santos,Laura Yébenes Gregorio,Maria Eugenia García Fernández,Javier Gimeno,Pablo Cannata Ortiz,Esther Roselló Sastre,Ana Saiz,Eduardo Salido Ruiz,Rosa Rodríguez,Cesáreo Corbacho Cuevas,Francisco Díaz Crespo,Yolanda Arce,Maria Soledad Garcia-Cuerva Calvar,Carles Saus,Carmen Guerrero Márquez,Adriana García-Herrera,Montserrat Gomà Gallego,Dolores López Álvarez,Cristina Meléndez Muñoz,Macarena Centeno,Belén Ferri Ñíguez,Juan Mosquera Reboredo,Eduardo Vázquez Martul,Sofía Pérez Gutiérrez +78 more
TL;DR: In this paper, the authors evaluated the performance of the C3G-HI in a new patient population and validated its performance as a predictor of kidney failure in patients with C3 glomerulopathy.
32